Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,675Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M220EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)21.5Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.5PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XLV

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

XLV is held by these investors:



XLV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.48680.49view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94336.78view
DINWOODIE, TYLER WAYNE PAULSenior Officer 2017-01-16Buy4,000$0.1743423.53view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.365340.44view
Bebek, IvanDirector 2017-01-16Buy8,990$3.382089.05view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4117946.34view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91165.1view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.271080.06view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.3822.54view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.1549226.67view

Quarterly/Annual Reports about XLV:

    News about XLV:

    Articles On GuruFocus.com
    S&P 500 Sector ETFs: A Look Under the Hood, Part 3 Mar 11 2015 
    Build a “Whatever Happens” Portfolio – Now! Aug 15 2014 
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    This Medical Device ETF Is Healthier Than its Sector Feb 21 2017
    Goldman Sachs and the Proposed Repeal of Obamacare Feb 21 2017
    Pisani: Trump rally still in tact Feb 17 2017
    Amgen Is Managing the Life Cycle of Its Mature Nephrology Drugs in 2017 Feb 17 2017
    Health Care ETF Has Been Ailing Feb 16 2017
    U.S. hospital stocks start 2017 strong as some Obamacare fears ease Feb 15 2017
    A Sound Diagnosis for this Healthcare ETF Feb 10 2017
    Zacks Market Edge Highlights: Health Care SPDR ETF, iShares NASDAQ Biotechnology ETF, Acadia, Aetna... Feb 09 2017
    Did the January Jobs Report Improve Confidence in the US Economy? Feb 09 2017
    Finding the Best Value Investment in Healthcare Feb 08 2017
    Trying To Beat The Market With Index ETFs Is Alive and Well Feb 08 2017
    What Bill Miller Thinks about Valeant Pharmaceuticals Feb 08 2017
    Healthcare Stocks: The Buying Opportunity of the Year? Feb 07 2017
    Final Trade: GM, NFLX & more Feb 07 2017
    UBS: A correction is coming Feb 06 2017
    Priced like an automaker, sputtering Gilead shares lure value bets Feb 06 2017
    A Bull Call On A Marquee Healthcare ETF Feb 06 2017
    Trading today's rally: 6 plays Feb 03 2017
    Merck matches profit expectations but sales come up a bit short Feb 02 2017
    How to Play Pfizer's Fourth-Quarter Results With ETFs Feb 01 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)